MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor
Stock Information for MIRA Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.